Su SC, Mockenhaupt M, Wolkenstein P, Dunant A, Le Gouvello S, Chen CB, et al
Tirzepatide (Zepbound) is FDA-approved for chronic weight management in adults with: BMI 30 (obesity) BMI 27 + weight-related condition (high blood pressure, diabetes, etc.) Consult your healthcare provider for eligibility.[mayoclinic] Can I Combine Tirzepatide with Semaglutide
Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using a random-effects model, with subgroup analyses by cancer type and exposure duration
Third, this analysis was conducted from the perspective of the Greek third-party payer (EOPYY) and therefore excluded indirect costs, such as productivity losses, absenteeism, presenteeism, and premature mortality, associated with obesity
There are ongoing CV outcome trials for #tirzepatide, #MariTide, #retatrutide, #survodutide and #CagriSema that will test whether these complementary pathways deliver additive protection beyond GLP1 alone